| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
RESEARCH |
Institute of Clinical Research, Centre for Reproduction and Early Life, University of Nottingham, Nottingham NG7 2UH, UK
Correspondence should be addressed to M E Symonds at Academic Division of Child Health, School of Human Development, University Hospital, Nottingham NG7 2UH, UK; Email: michael.symonds{at}nottingham.ac.uk
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
UCP2 has the most widespread tissue abundance and is present in the uterus of mice (Pecquer et al. 2001, Rousset et al. 2003). Its function remains a subject of intense debate (Stuart et al. 2001), but the abundance of UCP2 mRNA and/or protein has been shown to be developmentally regulated in both the lung and adipose tissue of sheep where one postulated role includes the regulation of apoptosis (Voehringer et al. 2000). In both these tissues, the abundance of UCP2 mRNA and protein is strongly influenced by the current and the past nutritional states (Mostyn et al. 2003, Gnanalingham et al. 2005a, 2005c). It is currently not known whether UCP2 is present in the placenta nor whether it is developmentally controlled or nutritionally responsive in utero. Therefore, an extension of our study was to determine whether UCP2 is present in the ovine placenta and if it is developmentally regulated. Other important mitochondrial proteins whose function is related to UCP2 include voltage-dependent anion channel (VDAC; Voehringer et al. 2000) located in the outer mitochondrial membrane (Colombini 1979). VDAC along with UCP2 (Voehringer et al. 2000) could be responsible for the release of cytochrome c from the intermembrane space, a process that has been implicated in the chain of events culminating in apoptosis (Crompton 1999). Placenta of clinically compromised pregnancies shows increased rates of apoptosis (Huppertz & Herrler 2005), but the extent to which apoptosis is enhanced by maternal NR has not been examined. We therefore aimed to determine not only the effect of maternal food intake on apoptosis but also the cellular location of VDAC and cytochrome c in the placenta.
Maternal dietary manipulation in early pregnancy results in a number of endocrine adaptations that may potentially impact on placental function. These include a reduction in the plasma concentrations of a range of maternal metabolic hormones including cortisol, thyroid hormones, insulin-like growth factor (IGF)-I, and insulin (Bispham et al. 2003, Symonds et al. 2007). A reduction in placental IGF type-I receptor (IGF-IR) is associated with intrauterine growth retardation (Reid et al. 2002, Laviola et al. 2005). The extent to which the same effect on the IGF-IR may result from changes in maternal nutrition is unknown and was a further aim of the present study. In order to achieve the aims of the study, placenta was sampled from control and nutritionally manipulated singleton-bearing sheep at:
| Results |
|---|
|
|
|---|
UCP2, GR, and 11ßHSD2 mRNA were all detected in the fetal placentome at 80 and 140 days gestation (Fig. 1A–C
). UCP2 and GR mRNA abundance increased (P<0.01) with gestational age and were further raised, compared with controls (P<0.01), by early to mid-gestational NR (Fig. 1A and B
). Interestingly, 11ßHSD2 mRNA abundance was lower (P<0.01) in the placenta of NR compared with control mothers at 80 days gestation (Fig. 1C
). It then only decreased with gestational age in controls with the result that by 140 days gestation 11ßHSD2 mRNA abundance was significantly greater in placenta sampled from NR mothers compared with controls. Finally, irrespective of maternal diet and gestational age UCP2 and GR mRNA abundance were positively correlated (Fig. 2
). IGF-IR mRNA abundance was decreased at 80 days gestation by NR, although by 140 days gestation this effect was negated by refeeding (Fig. 3
).
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
It is known that for adipose tissue during the period of exponential growth there is a strong correlation between total fat mass and both local glucocorticoid action and UCP2 expression (Gnanalingham et al. 2005a). In the present study on the ovine placenta, we found a positive relationship between UCP2 and GR mRNA with gestational age that is clearly not related to placental mass per se. The exact mechanisms by which both GR and UCP2 mRNA are up-regulated in the placenta remain to be established. Endocrine regulation of UCP2 during development has been most widely studied in fetal adipose tissue in which cortisol and the biologically active thyroid hormone, triiodothyronine (T3), both appear to be involved (Gnanalingham et al. 2005d). These hormones can affect local glucocorticoid action by specifically influencing the expression of GR and 11ßHSD isoforms. Indeed, regulation of fetal UCP2 mRNA by cortisol is in accord with the effects of umbilical cord occlusion which results in a precocious rise in UCP2 mRNA in the fetal lung and adipose tissue (Gnanalingham et al. 2005e). Under these adverse hypoxic conditions, however, it is cortisol, rather than T3, which regulates UCP2 abundance. In the present study, however, the endocrine mechanisms may be maternally driven as we have previously established that both maternal plasma cortisol and thyroid hormones are decreased over the period of NR (Bispham et al. 2003). It remains to be established whether these directly impact on placental glucocorticoid action and in particular increase its sensitivity to cortisol.
Interestingly, the increase in mitochondrial mRNA abundance for UCP2 was not accompanied by any change in VDAC or cytochrome c protein. This contrasts with adipose tissue in which nutritional programming of all of these proteins is observed (Mostyn et al. 2003) and emphasizes their tissue-specific regulation (Gnanalingham et al. 2005b, 2006). Unfortunately, we were unable to confirm whether UCP2 protein was similarly affected because of the current unavailability of specific antibodies for ovine UCP2 (Gnanalingham et al. 2005f). The functional consequence of an increase in placental UCP2 remains to be established. One putative role for UCP2 is in apoptosis (Voehringer et al. 2000), which, in the placenta, is determined in part by glucocorticoid sensitivity (Waddell et al. 2000). Apoptosis was, however, unaffected by NR in our study. Interestingly, we have shown for the first time that both VDAC and cytochrome c are located within the syncytial region of the placenta, which is the major site of glucose transport across the placenta (Dandrea et al. 2001). This process obviously requires appreciable amounts of energy, which will need to be met within the mitochondria, and does not appear to be impaired by reduced maternal food intake and the reduction in placental cell proliferation.
The persistent increase in placental GR mRNA abundance with maternal NR was not accompanied by a similar change in 11ßHSD2 mRNA, which was transiently decreased at 80 days, but then increased near to term. These data extend previous findings in which no effect of early to mid-gestational NR was found on 11ßHSD1 mRNA at term and a reduction in 11ßHSD2 was only present in mid-gestation (Whorwood et al. 2001). Unlike the present study that utilized RT-PCR, previous work may have been unable to detect this gene in term placenta because the less sensitive technique of Northern blotting was used (Whorwood et al. 2001). By term, the placentae of NR mothers demonstrate a marked up-regulation in 11ßHSD2 mRNA that is likely to be paralleled by an increase in 11ßHSD2 enzyme activity (Whorwood et al. 2001). The time course of this adaptation corresponds to the period in which maternal plasma cortisol adapts from being reduced during the period of NR to subsequently rising as the maternal diet is restored to the same level as controls (Bispham et al. 2003). Taken together, these findings indicate that it is not only the prevailing maternal cortisol that influences placental and, thus, fetal exposure to cortisol but it is the magnitude of change in the maternal circulation throughout pregnancy. As such, a transient rise in maternal cortisol in late gestation has no effect on fetal cortisol (Edwards & McMillen 2001). Indeed, the increase in placental 11ßHSD2 activity with gestation that only occurred in the nutrient-restricted group would be predicted to reduce fetal cortisol exposure (Langley-Evans et al. 1996). This may therefore be the mechanism by which fetal sensitivity is raised in these offspring, which is in direct contrast to the response of adipose tissue in offspring born to mothers nutrient restricted in late gestation (Gnanalingham et al. 2005a).
In contrast to the GR, mRNA abundance for the IGF-IR was decreased in placenta of NR mothers at 80, but not 140, days gestation. This coincided with the stage at which mean placentome mass was reduced and is in accord with findings in rats and humans in which intrauterine growth retardation is accompanied with reduced placental IGF-IR (Reid et al. 2002, Laviola et al. 2005). It should be noted, however, that the placenta is markedly different between sheep, rats, and humans which have discoid, hemochorial placenta, whereas in sheep placenta are cotyledonary synepitheliochorial that may represent an evolutionary development and can limit the transport of some molecules from the mother to fetus (Carter & Mess 2007). Therefore, in the sheep, restoration of the maternal diet together with the concomitant rise in maternal plasma IGF-I (Bispham et al. 2003) acts to restore placental responsiveness. At the same time, this adaptation is accompanied by a maintenance of placental mass, increased fetal length at term, and resetting of the relationship between fetal plasma IGF-I and body dimensions (Heasman et al. 2000).
In conclusion, we have shown that maternal NR targeted between the time of conceptus implantation throughout peak placental growth results in a pronounced change in local glucocorticoid action within the placenta, one consequence of which is increased UCP2 mRNA abundance. These adaptations occur in conjunction with a reduction in placental cell proliferation but in the absence of any affect on apoptosis. Changes in glucocorticoid action could then contribute to changes in cortisol exposure of the fetus, thereby, causing both immediate (Whorwood et al. 2001) and long-term changes in local glucocorticoid action and UCP2 abundance within specific offspring tissues (Gnanalingham et al. 2005a, 2005c).
| Materials and Methods |
|---|
|
|
|---|
In order to determine the effect of early to mid-gestational maternal NR on fetal placentome development, five sheep within each nutrition group were randomized to tissue sampling at either 80 or 140 days gestation. Each animal was humanely euthanized following i.v. administration of 200 mg/kg pentobarbital sodium (Euthatal: RMB Animal Health, Dagenham, UK). The entire uterus was removed from each animal and a number of randomly chosen A type placentomes as determined by their visual appearance (Vatnick et al. 1991) were sampled. These represent the majority of placentomes in the sheep (Clarke et al. 1998, Heasman et al. 1998) and were immediately dissected and either put into 10% (v/v) formalin and embedded in paraffin wax for subsequent histological analysis, or separated into maternal and fetal components and immediately placed in liquid nitrogen and stored at –80 °C for later analysis. In addition, total placental and fetal weights were recorded together with all major organs. All operative procedures and experimental protocols had the required Home Office approval as designated by the Animals (Scientific Procedures) Act (1986).
Laboratory analyses
mRNA detection
Total RNA was isolated from fetal placentome tissue using Tri-Reagent (Sigma) and the expression of UCP2, GR (type 2), 11ßHSD2, and IGF-IR mRNA determined by reverse transcriptase-PCR (RT-PCR) as described previously (Bispham et al. 2003, Gnanalingham et al. 2005c). The analysis used oligonucleotide cDNA primers to UCP2, GR (type 2), 11ßHSD2, and IGF-IR genes as published previously (Bispham et al. 2003, Gnanalingham et al. 2005c), whilst VDAC expression was determined using the primers of Cesar & Wilson (2004), all generating specific intron-spanning products. Standard curves for each gene were initially established in order to optimize the amount of cDNA required for each subsequent analysis. Agarose gel electrophoresis and ethidium bromide staining confirmed the presence of both the product and the ribosomal 18S, and densitometric analysis was performed using a Fujifilm LAS-1000 cooled charge-coupled device (CCD) camera. Consistency of lane loading for each sample was verified and all results expressed as a ratio of a reference sample to r18S abundance. All analyses and gels were conducted in duplicate.
Protein detection
Mitochondria and plasma membranes were prepared from ~1 g of fetal placentome (Budge et al. 2000) and protein content determined by the Lowry method (Lowry et al. 1951). Western blotting was utilized to measure the abundance of VDAC and cytochrome c mitochondrial proteins (Mostyn et al. 2003). Identical amounts of placental protein were loaded (i.e. 10 µg) onto each gel for each sample. Following electroblotting of the polyacrylamide gel onto a nitrocellulose membrane, Ponceau red staining was used to visually confirm that similar amounts of protein had been transferred before subjecting the membranes to immunodetection (Mostyn et al. 2003). Abundance of cytochrome c was determined using a specific antibody (sc-7159; Santa Cruz, Biotechnology Inc., Santa Cruz, USA) at a dilution of 1 in 1000. VDAC abundance was determined using an antibody raised in rabbits to ovine VDAC1, purified from the kidney of a newborn sheep (Mostyn et al. 2003) at a dilution of 1 in 2000. Densitometric analysis was performed using AIDA software (Aida version 2.0; raytest Isotopenmeßgeräte GmBH Straubenhardt, Germany) on each membrane following image detection using a Fujifilm LAS-1000 cooled CCD camera (Fuji Photo Film Co. Ltd, Tokyo, Japan). All values were expressed in densitometric units. Specificity of detection was confirmed using nonimmune rabbit serum. All gels were run in duplicate and a reference sample (placental mitochondria from a control sheep sampled at 140 days gestation) was included on each to allow comparison between gels.
In addition, further Western blots were performed to confirm the effects of maternal nutrition on GR and IGF-IR protein abundance. This was undertaken using polyclonal antibodies for each protein purchased from Santa Cruz (catalogue numbers SC 8992 and 713 respectively). Each antibody was tested at a range of dilutions from 1:150 to 1:1000 under both mild reducing and nonreducing conditions using up to 80 µg protein. Unfortunately, neither antibody yielded a concise signal (in any of the animals) that was in accord with its predicted molecular mass (i.e. signals were nonspecific). Nonspecificity of detected bands was confirmed through regression analysis of molecular weight markers to determine exact size and through incubation with nonimmune rabbit serum. All Western blots were run in duplicate and included a range of molecular weight markers and a positive reference sample (plasma membranes isolated from 1-day-old sheep).
Immunohistochemistry and assessment of apoptosis
To establish the cellular location of VDAC and cytochrome c within the placenta, immunohistochemistry was performed using the antibodies described above at dilutions ranging from 1:100 to 1:1000 (Dandrea et al. 2001). Following incubation with enzyme-conjugated second antibody and chromogen substrate, sections were examined by light microscopy. The specificity of the procedure was confirmed by the absence of binding when adjacent sections were incubated with rabbit serum from an unimmunized rabbit in place of rabbit anti-ovine primary antibody. It was not possible to perform the same analyses with respect to the location of UCP2 due to the lack of appropriately validated antibodies (Gnanalingham et al. 2005f). The same analyses were undertaken for the GR and IGF-IR, but in accord with our failure to detect protein at the correct molecular weight by Western blotting neither antibody showed specificity of binding to the placenta. This procedure was undertaken on 20–30 randomly selected sections from each nutritional group.
Measurement of cell proliferation within the placenta was also undertaken by determining the amount of immunoreactive proliferating cell nuclear antigen (PCNA) expression (Waseem & Lane 1990). This was undertaken using a mouse MAB to PCNA (PC10) (Alexis Biochemicals, Bingham, Nottingham) at a 1:200 dilution. Relative staining intensity for immunoreactive nuclear PCNA expression was visually assessed in a blinded manner and scored as either absent (–; no nuclear staining), weak ( +), moderate ( + +), or strong ( + + +) (Taylor et al. 2000). Immunohistochemistry was performed on a computerized Bond automated immunohistochemistry system (Vision Biosystems Limited, Newcastle-upon-Tyne, UK) using a bond polymer refine detection kit. A negative control was performed for each test section by omitting incubation in the primary antibody. Tonsil, in which PCNA staining is pronounced, was used as the positive control (Waseem & Lane 1990). Sections were dehydrated in ascending concentrations of alcohol and xylene before coverslips were mounted.
These sections were also used to assess the relative incidence of apoptosis by the TUNEL assay (Roche Diagnostics; Gavrieli et al. 1992). Sections were stored at 4 °C in the dark and the magnitude of staining analyzed within 48 h. Appropriate negative controls were included to assess both nonspecific binding and the extent of autofluorescence. Positive controls were treated with DNase type I to produce fragmentation of chromosomal DNA and washed separately to prevent any residual DNase activity affecting other sections. All analyses were performed using the same assessor who was blinded to nutritional grouping using reference slides to check consistency of grading assessment. To assess the relative incidence of apoptosis between groups, slides were analyzed using fluorescence microscopy with FITC and u.v. filters to visualize green (fragmented DNA) and a semi-quantitative apoptosis index (0–4; Lepault et al. 2005) used. This procedure was undertaken on 30 randomly selected sections from each nutritional group at a magnification of 200x . In addition, as the TUNEL reaction is unable to discriminate apoptotic from necrotic cells, caspase-3, a marker of early apoptosis (Gown & Willingham 2002) was localized using a rabbit anti-caspase 3 polyclonal antibody (Abcam plc, Cambridge, UK) diluted 1:50. Immunohistochemistry was performed using the Bond automated system with a bond polymer refine detection kit (Vision Biosystems Limited). A negative control was performed for each test section by omitting incubation in the primary antibody. Tonsil, in which apoptosis is pronounced, was used as the positive control (Krajewska et al. 1997). For each section, the number of positive cells in five randomly selected fields was used to calculate the mean positive cell count ± S.E.M per 200x field.
Statistical analysis
All data are presented as the means ± S.E.M. Significant differences (P<0.05) between gestational ages and nutritional groups were analyzed by ANOVA. Significant correlations between molecular parameters were assessed by Spearmans Rank Order Test (SPSS v11.0; SPSS Inc., Chicago, Illinois, USA).
| Acknowledgements |
|---|
|
|
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Agricultural Research Council 1980 Requirements for energy, The Nutritional Requirements of Ruminant Livestock, Slough, UK: Commonwealth Agricultural Bureau.
Bamberger CM, Schulte HM & Chrousos GP 1996 Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocrinology Reviews 17 245–261.
Barker DJP 2001 The malnourished baby and infant. British Medical Bulletin 60 69–88.
Bispham J, Gopalakrishnan GS, Dandrea J, Wilson V, Budge H, Keisler DH, Broughton Pipkin F, Stephenson T & Symonds ME 2003 Maternal endocrine adaptation throughout pregnancy to nutritional manipulation: consequences for maternal plasma leptin and cortisol and the programming of fetal adipose tissue development. Endocrinology 144 3575–3585.
Budge H, Bispham J, Dandrea J, Evans E, Heasman L, Ingleton PM, Sullivan C, Wilson V, Stephenson T & Symonds ME 2000 Effect of maternal nutrition on brown adipose tissue and its prolactin receptor status in the fetal lamb. Pediatric Research 47 781–786.[Web of Science][Medline]
Carter AM & Mess A 2007 Evolution of the placenta in Eutherian mammals. Placenta 28 295–262.
Cesar MC & Wilson JE 2004 All three isoforms of the voltage-dependent anion channel (VDAC1, VDAC2, and VDAC3) are present in mitochondria from bovine, rabbit, and rat brain. Archives of Biochemistry and Biophysics 422 191–196.[CrossRef][Web of Science][Medline]
Clarke L, Heasman L, Juniper DT & Symonds ME 1998 Maternal nutrition in early-mid gestation and placental size in sheep. British Journal of Nutrition 79 359–364.[CrossRef][Web of Science][Medline]
Colombini M 1979 A candidate for the permeability pathway of the outer mitochondrial membrane. Nature 279 643–645.[CrossRef][Medline]
Crompton M 1999 The mitochondrial permeability transition pore and its role in cell death. Biochemical Journal 341 233–249.[CrossRef][Web of Science][Medline]
Dandrea J, Wilson V, Gopalakrishnan G, Heasman L, Budge H, Stephenson T & Symonds ME 2001 Maternal nutritional manipulation of placental growth and glucose transporter-1 abundance in sheep. Reproduction 122 793–800.[Abstract]
Demasi MA, Montor WR, Ferreira GB, Pimenta DC, Labriola L & Sogayar MC 2007 Differential proteomic analysis of the anti-proliferative effect of glucocorticoid hormones in ST1 rat glioma cells. Journal of Steroid Biochemistry Molecular Biology 103 137–148.[CrossRef][Web of Science][Medline]
Edwards LJ & McMillen IC 2001 Maternal undernutrition increases arterial blood pressure in the sheep fetus during late gestation. Journal of Physiology 533 561–570.
Ehrhardt RA & Bell AW 1995 Growth and metabolism of the ovine placenta during mid-gestation. Placenta 16 727–741.[CrossRef][Web of Science][Medline]
Gavrieli Y, Sherman Y & Ben-Sasson SA 1992 Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. Journal of Cell Biology 119 493–501.
Gnanalingham MG, Mostyn A, Symonds ME & Stephenson T 2005a Ontogeny and nutritional programming of adiposity: potential role of glucocorticoid sensitivity and uncoupling protein-2. American Journal of Physiology 289 R1407–R1415.[Web of Science]
Gnanalingham MG, Mostyn A, Gardner DS, Stephenson T & Symonds ME 2005b Developmental regulation of adipose tissue: nutritional manipulation of local glucocorticoid action and uncoupling protein 2. Adipocytes 1 221–228.
Gnanalingham MG, Mostyn A, Dandrea J, Yakubu DP, Symonds ME & Stephenson T 2005c Ontogeny and nutritional programming of uncoupling protein-2 and glucocorticoid receptor mRNA in the ovine lung. Journal of Physiology 565 159–169.
Gnanalingham MG, Mostyn A, Forehead AJ, Fowden AL, Symonds ME & Stephenson T 2005d Increased uncoupling protein-2 mRNA abundance and glucocorticoid sensitivity in adipose tissue in the sheep fetus during late gestation is dependent on plasma cortisol and triiodothyronine. Journal of Physiology 567 283–292.
Gnanalingham MG, Giussani DA, Sivathondan P, Forehead AJ, Stephenson T, Symonds ME & Gardner DS 2005e Chronic umbilical cord compression results in premature maturation of lung and brown adipose tissue in the late gestation ovine fetus. American Journal of Physiology 289 E456–E465.[Web of Science]
Gnanalingham MG, Mostyn A, Webb R, Keisler DH, Raver N, Alves-Guerra MC, Pecqueur C, Miroux B, Symonds ME & Stephenson T 2005f Differential effects of leptin administration on the abundance of uncoupling protein-2 and glucocorticoid action during neonatal development. American Journal of Physiology 289 E1093–E1100.[Web of Science]
Gnanalingham MG, Mostyn A, Gardner DS, Stephenson T & Symonds ME 2006 Developmental regulation of the lung in preparation for life after birth: nutritional manipulation of local glucocorticoid action and uncoupling protein 2. Journal of Endocrinology 188 375–386.
Gown AM & Willingham MC 2002 Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. Journal of Histochemistry and Cytochemistry 50 449–454.
Heasman L, Clarke L, Firth K, Stephenson T & Symonds ME 1998 Influence of restricted maternal nutrition in early to mid gestation on placental and fetal development at term in sheep. Pediatric Research 44 546–551.[Web of Science][Medline]
Heasman L, Brameld JM, Mostyn A, Budge H, Dawson J, Buttery PJ, Stephenson T & Symonds ME 2000 Maternal nutrient restriction during early to mid gestation alters the relationship between IGF-I and body size at term in fetal sheep. Reproduction, Fertility and Development 12 345–350.[CrossRef][Medline]
Huppertz B & Herrler A 2005 Regulation of proliferation and apoptosis during development of the preimplantation embryo and the placenta. Birth Defects Research. Part C, Embryo Today: Reviews 75 249–261.[CrossRef]
Krajewska M, Wang HG, Krajewski S, Zapata JM, Shabaik A, Gascoyne R & Reed JC 1997 Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Research 57 1605–1613.
Langley-Evans SC, Phillips GJ, Benediktsson R, Gardner DS, Edwards CR, Jackson AA & Seckl JR 1996 Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat. Placenta 17 169–172.[Web of Science][Medline]
Laviola L, Perrini S, Belsanti G, Natalicchio A, Montrone C, Leonardini A, Vimercati A, Scioscia M, Selvaggi L, Giorgino R, et al. 2005 Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology 146 1498–1505.
Lepault E, Celeste C, Dore M, Martineau D & Theoret CL 2005 Comparative study on microvascular occlusion and apoptosis in body and limb wounds in the horse. Wound Repair and Regeneration 13 520–529.[CrossRef][Web of Science][Medline]
Lowry OH, Rosenbrough NJ, Farr AL & Randall RJ 1951 Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 265–275.
McMillen IC & Robinson JS 2005 Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiological Reviews 85 571–633.
Mostyn A, Wilson V, Dandrea J, Yakubu DP, Budge H, Alves-Guerra MC, Pecqueur C, Miroux B, Symonds ME & Stephenson T 2003 Ontogeny and nutritional manipulation of mitochondrial protein abundance in adipose tissue and the lungs of postnatal sheep. British Journal of Nutrition 90 323–328.[CrossRef][Web of Science][Medline]
Pecquer C, Alves-Guerra M-C, Gelly C, Lévi-Meyrueis C, Couplan E, Collins S, Ricquier D, Bouillaud F & Miroux B 2001 Uncoupling protein-2: in vivo distribution, induction upon oxidative stress and evidence for translational regulation. Journal of Biological Chemistry 276 8705–8712.
Reid GJ, Flozak AS & Simmons RA 2002 Placental expression of insulin-like growth factor receptor-1 and insulin receptor in the growth-restricted fetal rat. Journal of the Society for Gynecologic Investigations 9 210–214.[CrossRef]
Rogatsky I, Trowbridge JM & Garabedian MJ 1997 Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Molecular Cell Biology 17 3181–3193.
Rousset S, Alves-Guerra M-C, Ouadghiri-Bencherif S, Kozak LP, Miroux B, Richard D, Bouillaud F, Ricquier D & Cassard-Doulcier A-M 2003 UCP2 is expressed in the female mice reproductive tract whereas UCP1 is not. Journal of Biological Chemistry 278 45843–45847.
Stegmann JHJ 1974 Placental development in sheep. Bijdragen tot de Dierkunde 44 4–72.
Stewart PM & Krozowski ZS 1999 11b-Hydroxysteroid dehydrogenase. Vitamins and Hormones 57 249–324.[Web of Science][Medline]
Stuart JA, Harper JA, Brindle KM, Jekabsons MB & Brand MD 2001 Physiological levels of mammalian uncoupling protein 2 do not uncouple yeast mitochondria. Journal of Biological Chemistry 276 18633–18639.
Symonds ME, Budge H, Stephenson T & Gardner DS 2005 Leptin, fetal nutrition and long term outcomes for adult hypertension. Endothelium 12 73–79.[CrossRef][Web of Science][Medline]
Symonds ME, Budge H, Mostyn A, Stephenson T & Gardner DS 2007 Maternal diet through pregnancy – the key to future good health of the next generation. In Reducing Diets: New research, Ed. SV Watkins. New York: Nova Science Publishers, Inc.
Taylor KM, Gray CA, Joyce MM, Stewart MD, Bazer FW & Spencer TE 2000 Neonatal ovine uterine development involves alterations in expression of receptors for estrogen, progesterone, and prolactin. Biology of Reproduction 63 1192–1204.
Vatnick I, Schoknecht PA, Darrigrand R & Bell AW 1991 Growth and metabolism of the placenta after unilateral fetectomy in twin pregnant ewes. Journal of Developmental Physiology 15 351–356.[Web of Science][Medline]
Voehringer DW, Hirschberg DL, Xiao J, Lu Q, Roederer M, Lock CB, Herzenberg LA, Steinman L & Herzenberg LA 2000 Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. PNAS 97 2680–2685.
Waddell BJ, Hisheh S, Dharmarajan AM & Burton PJ 2000 Apoptosis in rat placenta is zone-dependent and stimulated by glucocorticoids. Biology of Reproduction 63 1913–1917.
Waseem NH & Lane DP 1990 Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. Journal of Cell Science 96 121–129.
Whorwood CB, Firth KM, Budge H & Symonds ME 2001 Maternal undernutrition during early- to mid-gestation programmes tissue-specific alterations in the expression of the glucocorticoid receptor, 11b-hydroxysteroid dehydrogenase isoforms and type 1 angiotensin II receptor in neonatal sheep. Endocrinology 142 2854–2864.
This article has been cited by other articles:
![]() |
S P Sebert, M A Hyatt, L L Y Chan, M Yiallourides, H P Fainberg, N Patel, D Sharkey, T Stephenson, S M Rhind, R C Bell, et al. Influence of prenatal nutrition and obesity on tissue specific fat mass and obesity-associated (FTO) gene expression Reproduction, January 1, 2010; 139(1): 265 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Yiallourides, S P Sebert, V Wilson, D Sharkey, S M Rhind, M E Symonds, and H Budge The differential effects of the timing of maternal nutrient restriction in the ovine placenta on glucocorticoid sensitivity, uncoupling protein 2, peroxisome proliferator-activated receptor-{gamma} and cell proliferation Reproduction, September 1, 2009; 138(3): 601 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
D P Yakubu, A Mostyn, M A Hyatt, L O Kurlak, H Budge, T Stephenson, and M E Symonds Ontogeny and nutritional programming of mitochondrial proteins in the ovine kidney, liver and lung Reproduction, December 1, 2007; 134(6): 823 - 830. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |